Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1984 Jan;37(1):56–58. doi: 10.1136/jcp.37.1.56

The fibrinolytic system in pre-eclampsia.

L Gow, D M Campbell, D Ogston
PMCID: PMC498618  PMID: 6423699

Abstract

Plasma fibrinolytic activity and plasma inhibitory activity against urokinase and tissue activator were measured in primigravidae with moderate or severe pre-eclampsia and in gestation-matched primigravidae with uncomplicated pregnancy. The mean levels of fibrinolytic activity and inhibitory activity against urokinase and tissue activator did not differ significantly between the pre-eclampsia and uncomplicated pregnancy groups. The pattern of inhibitory fractions of plasminogen-depleted plasma from pre-eclamptic and uncomplicated primigravidae after gel filtration on sephadex G-100 was similar.

Full text

PDF
56

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beattie A. G., Ogston D., Bennett B., Douglas A. S. Inhibitors of plasminogen activation in human blood. Br J Haematol. 1976 Jan;32(1):135–143. doi: 10.1111/j.1365-2141.1976.tb01883.x. [DOI] [PubMed] [Google Scholar]
  2. Bonnar J., McNicol G. P., Douglas A. S. Coagulation and fibrinolytic systems in pre-eclampsia and eclampsia. Br Med J. 1971 Apr 3;2(5752):12–16. doi: 10.1136/bmj.2.5752.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Condie R. G., Ogston D. Sequential studies on components of the haemostatic mechanism in pregnancy with particular reference to the development of pre-eclampsia. Br J Obstet Gynaecol. 1976 Dec;83(12):938–942. doi: 10.1111/j.1471-0528.1976.tb00779.x. [DOI] [PubMed] [Google Scholar]
  4. Gow L., Campbell D. M., Ogston D. Blood levels of proteinase inhibitors in pre-eclampsia. Br J Obstet Gynaecol. 1983 Oct;90(10):950–952. doi: 10.1111/j.1471-0528.1983.tb06768.x. [DOI] [PubMed] [Google Scholar]
  5. Howie P. W., Prentice C. R., McNicol G. P. Coagulation, fibrinolysis and platelet function in pre-eclampsia, essential hypertension and placental insufficiency. J Obstet Gynaecol Br Commonw. 1971 Nov;78(11):992–1003. doi: 10.1111/j.1471-0528.1971.tb00216.x. [DOI] [PubMed] [Google Scholar]
  6. NELSON T. R. A clinical study of pre-eclampsia. I. J Obstet Gynaecol Br Emp. 1955 Feb;62(1):48–57. doi: 10.1111/j.1471-0528.1955.tb14094.x. [DOI] [PubMed] [Google Scholar]
  7. Rickli E. E., Zaugg H. Isolation and purification of highly enriched tissue plasminogen activator from pig heart. Thromb Diath Haemorrh. 1970 Feb 28;23(1):64–76. [PubMed] [Google Scholar]
  8. Walker J. E., Gow L., Campbell D. M., Ogston D. The inhibition by plasma of urokinase and tissue activator-induced fibrinolysis in pregnancy and the puerperium. Thromb Haemost. 1983 Feb 28;49(1):21–23. [PubMed] [Google Scholar]
  9. Walker J. E., Ogston D. The inhibition of tissue activator and urokinase by human plasma. Thromb Haemost. 1982 Jun 28;47(3):265–268. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES